Supplemental oxygen administration was first noted to correct signs and symptoms of hypoxic respiratory failure more than a century ago. 1,2 Since that time, oxygen has become one of the most widely administered therapeutic interventions in medicine. The prevention or reversal of hypoxia can be lifesaving, but excessive oxygen supplementation and resulting hyperoxia promotes resorption atelectasis and free radical formation leading to oxidative damage to tissues, endothelial dysfunction, and other deleterious effects. 3 The optimal dose of supplemental oxygen has been explored in several randomized clinical trials. A single-center trial that included 434 patients in a general intensive care unit (ICU) population and compared oxygen titration to a partial pressure of arterial oxygen (PaO 2 ) of 70 to 100 mm Hg (arterial oxygen saturation [SpO 2 ] of 94%-98%) vs titration to a PaO 2 up to 150 mm Hg (SpO 2 of 97%-100%) found that the lower oxygenation goals reduced mortality. 4 By contrast, subsequent multicenter trials that included general ICU patients (sample sizes of 965, 400, and 2928 patients), [5][6][7] as well as patients with acute respiratory distress syndrome (n = 205) 8 or myocardial infarction (n = 6629) 9 found no benefit from lower oxygen targets.It is uncertain whether data from ICU-based trials in other patient populations generalize to the out-of-hospital and emergency department treatment of patients resuscitated from cardiac arrest. The pathophysiological sequelae of pulselessness and cardiopulmonary resuscitation may increase susceptibility to and potential harm from both hypoxia and hyperoxia in a manner that changes rapidly in the minutes after return of spontaneous circulation (ROSC). Respiratory failure is a common antecedent cause of cardiac arrest, whereas aspiration, pulmonary contusions, atelectasis, and hypotension develop in most patients who are resuscitated and contribute to ventilation-perfusion mismatch and hypoxemia. [10][11][12] Even when SpO 2 and PaO 2 values are within normal range, perivascular edema in the brain can cause tissue hypoxia that may contribute to secondary brain injury after ROSC. 13,14 Conversely, reperfusion injury is a major contributor to organ dysfunction after ROSC that is worsened by hyperoxia. 15 Postarrest hyperoxia may also reduce cerebral blood flow and cardiac output by increasing vascular resistance. 16 In this issue of JAMA, Bernard et al 17 report a multicenter clinical trial that randomized adult patients with ROSC after out-of-hospital cardiac arrest and advanced airway placement to receive rapid reduction in supplemental oxygen delivery targeting an SpO 2 of 90% to 94% or high-flow supplemental oxygen targeting an SpO 2 of 98% to 100%. Paramedics randomized eligible patients and initiated the study interven-